Skip to content

Impact of Microbiome in Endometriosis Development

Impact of Microbiome in Endometriosis Development

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07576361
Acronym
ENDOBIOME
Enrollment
48
Registered
2026-05-08
Start date
2020-11-25
Completion date
2021-11-17
Last updated
2026-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Keywords

C.Albicans, dysbiosis, endometriosis, inflammation

Brief summary

Endometriosis is a chronic disease, of which the pathophysiology is still unknown. Several theories exist, the one of menstrual blood flow has been retained until now but does not fully explain it. The main symptoms are dysmenorrhea, dyspareunia and infertility. The aim of this study is to evaluate the impact of c.albicans colonization of vaginal microbioma in development of endometriosis

Detailed description

Endometriosis is a chronic disease and its pathophysiology is still unknown. Several theories exist, the one of menstrual blood flow has been retained until now but does not fully explain it. The main symptoms are dysmenorrhea, dyspareunia and infertility. There is a large number of women with endometriosis without clinical manifestations, as well as those who suffer from it with an impact on their personal and professional lives. The estimation of prevalence is complicated since medical imagery is not conclusive in all cases and the gold-standard of diagnosis remains laparoscopy. The estimated overall prevalence is 10%. There is the notion that prevalence is higher in the Caribbean population. Recent studies have demonstrated the essential role of immunological factors and angiogenesis in the pathogenesis of endometriosis. Thus it has been shown the impact of pro-inflammatory cytokines (TNF-a, MCP-1, IL-6 IL 8) in the development and survival of endometriotic cells. The impact of the microbiome in the occurrence of certain pathologies (cancers...) and in the promotion of the carrying of infections (high risk HPV) is known. Candida albicans is a fungus widely present in normal human microbiome but its hyphae have a virulent potential that intensify the production of inflammatory cytokines via the MAPK/MKP1 /C-Fos regulatory route. This could cause endometriosis depending on the immune status of the host (pro-inflammatory context). We also speak of the "inflammasome" induced by C. albicans causing a local inflammatory reaction leading to a cascade of inflammation and the development of endometriosis The essential role of immunological factors and angiogenesis in the pathogenesis of endometriosis has been demonstrated with the impact of pro-inflammatory cytokines (TNF-a, MCP-1, IL-6 IL 8) on the development and survival of endometriotic cells. The interaction between the host genome and its microbiome is known. Candida albicans is a fungus widely present in normal human microbiome but its hyphae have a virulent potential that intensify the production of inflammatory cytokines via the MAPK/MKP1/C-Fos regulatory route. This is supposed to cause endometriosis depending on the immune status of the host (pro-inflammatory context). We also speak of the "inflammasome" induced by C. albicans causing a local inflammatory reaction leading to a cascade of inflammation and the development of endometriosis. The study will be proposed to patients during their gynecological consultation at the University Hospital of Guadeloupe. The participation to the study includes a questionnaire with epidemiological and medical data and a biospecimen collection containing a vaginal and oral swab and a saliva sample.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire de la Guadeloupe
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

For cases : aged 18-50 years old With confirmed or highly suspected endometriosis Affiliated to a social security system For controls: -aged 18-50 years old No confirmed or highly suspected Affiliated to a social security system

Exclusion criteria

Minors; Pregnant women; Protected persons, or persons placed under the protection of justice; Refusal to participate

Design outcomes

Primary

MeasureTime frameDescription
vaginal dysbiosis with C. albicansAt inclusioncomparison of percentages between the two groups

Secondary

MeasureTime frameDescription
correlation between vaginal dysbioses and the presence of Candida hyphaeAt inclusionpresence or absence of the HWP1 gene
impact of endometriosis on HPVhr carryingAt inclusionCarriage of high-risk HPV (hrHPV) defined by the presence of one or more genotypes identified using the Innolipa® detection kit
inflammatory biological markers involved in the endometriotic processAt inclusion"Expression of matrix metalloproteinases (MMPs)

Countries

Guadeloupe

Contacts

PRINCIPAL_INVESTIGATORGÜLEN AYHAN, Doctor

CHU de la Guadeloupe

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 9, 2026